Domov › Rak dojke › Ohio › Cincinnati
Klinične študije za Rak dojke v Cincinnati, OH
25 študij za Rak dojke išče udeležence na lokacijah v Cincinnati in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- in še 3
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Vključevanje udeležencevFaza 3
- TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0020), Cincinnati
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Vključevanje udeležencevFaza 3
- Good Samaritan Hospital-TriHealth Cancer institute ( Site 0027), Cincinnati
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Vključevanje udeležencevFaza 3
- Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053), Edgewood · 8 mi stran
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Vključevanje udeležencevFaza 3
- University of Cincinnati Medical Center, Cincinnati
- University of Cincinnati Medical Center - West Chester Hospital, West Chester · 15 mi stran
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Cincinnati
- Research Site, Cincinnati
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Clinical Trial Site, Cincinnati
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mi stran
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi stran
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Research Site, Edgewood · 8 mi stran
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of Cincinnati Medical Center, Cincinnati
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Vključevanje udeležencevOpazovalna študija
- University of Cincinnati Medical Center, Cincinnati
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- The Christ Hospital, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- in še 2
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- St. Elizabeth Healthcare, Edgewood · 8 mi stran
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Vključevanje udeležencevFaza 3
- Oncology Hematology Care, Cincinnati
E-Mindfulness Approaches for Living After Breast Cancer
Vključevanje udeležencevFaza 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi stran
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
Vključevanje udeležencev
- University of Cincinnati, Cincinnati
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Vključevanje udeležencevFaza 2
- The Christ Hospital Cancer Center, Cincinnati
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Vključevanje udeležencevFaza 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi stran
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Vključevanje udeležencevOpazovalna študija
- St. Elizabeth Edgewood Hospital, Edgewood · 8 mi stran
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
Vključevanje udeležencevFaza 4
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Cincinnati
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Vključevanje udeležencevFaza 3
- The Christ Hospital, Cincinnati
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi stran
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Vključevanje udeležencevOpazovalna študija
- TriHealth Cancer Institutes, Cincinnati
- Oncology Hematology Care, Cincinnati
Študije za Rak dojke v drugih mestih
- New York City, NY134 študij
- Houston, TX126 študij
- Boston, MA111 študij
- Nashville, TN80 študij
- Los Angeles, CA72 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Durham, NC63 študij
- Queens, NY63 študij
- Chicago, IL58 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Cincinnati
- Nemalicelični pljučni rak35 študij
- Rak (vse vrste)27 študij
- Srčno popuščanje24 študij
- Kolorektalni rak21 študij
- Akutna mieločna levkemija20 študij
- Metastatski rak20 študij
- Rak jajčnikov19 študij
- Rak pljuč19 študij
- Debelost19 študij
- Rak prostate18 študij
- Množni mielom17 študij
- Melanom17 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.